PT 141 hyperpigmentation is a real side effect: bremelanotide can darken skin by activating melanin receptors. Here's how common it is and what to do.
Yes, PT-141 (bremelanotide) can cause hyperpigmentation. The drug activates melanocortin receptors, and one of them — MC1R — signals skin cells to make more melanin, the pigment that darkens skin. In the clinical trials behind its FDA approval, focal hyperpigmentation was reported in roughly 1% of patients, so the effect is uncommon but well documented.
Why a Sexual-Desire Drug Affects Skin Pigment
Bremelanotide is a synthetic peptide modeled on alpha-melanocyte-stimulating hormone, a natural hormone involved in both sexual desire and skin pigmentation. Its main target is MC4R, a receptor in the brain tied to sexual desire. But the peptide is not perfectly selective, and it can also activate MC1R, the receptor that controls melanin production.
That overlap is why a medication sold for low sexual desire keeps showing up in searches about darkening skin. It also explains why the effect is usually mild and patchy rather than a full-body tan.
Does PT-141 Cause Tanning?
Not reliably, and not by design. PT-141 is not a tanning peptide, and it is not approved for cosmetic skin darkening. The peptide that dominates tanning forums is melanotan II, a close chemical cousin with far stronger MC1R activity.
People searching does pt 141 cause tanning usually notice the family resemblance between the two peptides and assume the effects are identical. They are not: melanotan II was developed to tan, while bremelanotide was developed for sexual desire.
| Feature | PT-141 (bremelanotide) | Melanotan II |
|---|---|---|
| FDA status | Approved as an injection for low sexual desire in premenopausal women | Not approved for any human use |
| Main receptor target | MC4R, with weaker MC1R activity | MC1R and MC4R, with strong pigmentation effects |
| Tanning effect | Weak and inconsistent | Strong; widely used off-label to tan |
| Reported hyperpigmentation | Focal hyperpigmentation in about 1% of trial patients | Common, and often the intended effect |
| Typical use | 1.75 mg subcutaneous injection, prescription only | Unregulated injections or nasal products |
How Common Is PT-141 Hyperpigmentation?
The prescribing information for the approved injectable lists focal hyperpigmentation as a warning, and patients are advised to stop treatment if new or worsening darkening appears. PT-141 hyperpigmentation occurred in about 1% of participants in the trials that supported approval.
Focal means the color change appears in specific spots rather than across the whole body. Reported sites include the face, the gums, and the breasts. Some users also describe darkened skin at injection sites.
What PT-141 Skin Darkening Looks Like
- Darker patches on the face, especially the cheeks, forehead, or upper lip
- Brownish discoloration of the gums, known as gingival hyperpigmentation
- Darkening of the areolas or surrounding breast skin
- New or darkening moles and freckles, though this is far more common with melanotan II
Changes generally develop gradually over days to weeks of repeated use. A single dose of PT-141 is unlikely to visibly change your skin color.
PT-141 Nasal Spray, Dosing, and Gray-Market Products
The only FDA-approved version is a 1.75 mg subcutaneous injection. Compounded and gray-market products, including pt-141 nasal spray, are not FDA-approved, and their actual strength can vary widely from one batch to the next.
The approved pt-141 dosage for women with hypoactive sexual desire disorder is 1.75 mg injected under the skin of the abdomen or thigh, at least 45 minutes before anticipated sexual activity, no more than once every 24 hours and no more than eight times per month. Taking more than the labeled dose does not appear to improve results and may increase side effects such as nausea and blood pressure changes.
PT-141 is not approved for men, and pt-141 for men is off-label use that carries the same pigmentation and blood pressure concerns. Because the injectable requires a prescription, where to buy pt-141 safely is a question for a licensed clinician rather than a research-chemical vendor.
Does the Darkening Fade After You Stop?
People often ask how long does pt-141 last, and the drug itself clears quickly — its half-life is roughly 2.7 hours, with effects on desire usually wearing off within a few hours. Pigment changes run on a much slower timeline.
Melanin sits in skin cells that turn over across weeks and months, so darkening linked to PT-141 often fades gradually after the drug is stopped. Some users report patches that linger or never fully resolve, particularly on the face.
What to Do If You Notice Skin Changes
Stop using the peptide and contact the clinician who prescribed or advised it. The approved label specifically recommends discontinuing treatment if new or worsening focal hyperpigmentation develops.
See a dermatologist for any new, changing, or irregular mole, since pigment changes can have causes unrelated to peptides. Anyone using PT-141 mainly to get darker skin should know the injectable is not approved for that purpose, and unsupervised tanning peptides have been linked to serious harms.
Key Takeaways
- PT-141 hyperpigmentation is a real but uncommon side effect, reported in roughly 1% of patients in the trials that led to FDA approval.
- PT-141 is not an effective tanning agent, and the FDA has not approved it for cosmetic skin darkening.
- Melanotan II is the peptide actually associated with tanning, and it is not approved for human use.
- Pigment changes from PT-141 may fade over weeks to months after stopping, but some cases persist.
- Only the 1.75 mg subcutaneous injection is FDA-approved, and any use should be supervised by a healthcare professional.
Frequently Asked Questions
Does PT-141 really cause hyperpigmentation?
Yes, but it is uncommon. In trials of the FDA-approved injectable, focal hyperpigmentation was reported in about 1% of patients, most often on the face, gums, or breasts. The prescribing information advises patients to stop treatment if new or worsening focal hyperpigmentation appears.
Is PT-141 the same as the tanning peptide melanotan II?
They are not the same. Both are melanocortin receptor agonists, but melanotan II binds the pigmentation receptor MC1R much more strongly and is widely used off-label for tanning. PT-141 is FDA-approved only for low sexual desire in premenopausal women and is a weak, unreliable tanning agent.
Will skin darkening from PT-141 go away?
It often fades over weeks to months after the drug is stopped, because melanin is gradually cleared as skin cells turn over. Some users report lingering patches, especially on the face. A dermatologist can evaluate persistent or changing areas of pigmentation.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.